AK Medical Holdings Ltd. (HK:1789)
:1789
Want to see HK:1789 full AI Analyst Report?
1789 Stock Chart & Stats
HK$5.91
-HK$0.05(-1.15%)
At close: 4:00 PM EST
HK$5.91
-HK$0.05(-1.15%)
Day’s Range― - ―
52-Week RangeHK$5.20 - HK$7.24
Previous CloseN/A
Volume3.85M
Average Volume (3M)4.30M
Market Cap
HK$6.52B
Enterprise ValueHK$5.38B
Total Cash (Recent Filing)HK$1.47B
Total Debt (Recent Filing)HK$144.79M
Price to Earnings (P/E)16.5
Beta1.03
Next Earnings
Sep 02, 2026EPS Estimate
0.19Next Dividend Ex-DateN/A
Dividend Yield1.26%
Share Statistics
EPS (TTM)0.30
Shares Outstanding1,124,616,700
10 Day Avg. Volume3,969,892
30 Day Avg. Volume4,297,109
Financial Highlights & Ratios
PEG Ratio0.84
Price to Book (P/B)1.97
Price to Sales (P/S)3.87
P/FCF Ratio18.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.08Price Target Upside36.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.36
Revenue Forecast (FY)HK$1.67B
Bulls Say, Bears Say
Bulls Say
High Profitability MarginsSustained high gross and operating margins indicate durable pricing power and efficient manufacturing in orthopaedic implants. Margins near 60% (gross) and ~23% (EBIT) support internal R&D, product investment and resilient earnings, helping the business absorb moderate volume swings.
Very Low Financial LeverageAn exceptionally low debt-to-equity ratio and steadily rising equity provide strong financial flexibility. This reduces refinancing and solvency risk, enables sustained capex or selective M&A, and supports consistent capital allocation through industry cycles without burdening cash flow.
Focused Business Model With Revenue GrowthA clear, focused product portfolio centered on joint replacement implants drives repeatable hospital demand. Mid-single to double-digit revenue growth indicates adoption momentum; the specialist medical-device model supports durable customer relationships and predictable procedure-driven sales.
Bears Say
Volatile Cash GenerationMaterial swings in operating and free cash flow across years weaken cash-conversion reliability. Inconsistent cash generation complicates multi-year planning for reinvestment, dividend coverage and capital returns, increasing reliance on prudent balance-sheet buffers to fund growth.
Revenue And Margin Volatility HistoryPeriods of revenue declines and margin normalization versus prior peaks show the business can be cyclical and sensitive to market/tender dynamics. This history reduces predictability of future growth and implies forecasts must account for downside variability across cycles.
Concentration On Hospital Procurement/tendersHeavy reliance on institutional purchasing and tender outcomes concentrates exposure to policy, procurement cycles and pricing pressure. That limits revenue diversification and makes top-line sensitive to procedure volumes and changes in hospital buying behavior over time.
AK Medical Holdings Ltd. News
1789 FAQ
What was AK Medical Holdings Ltd.’s price range in the past 12 months?
AK Medical Holdings Ltd. lowest stock price was HK$5.20 and its highest was HK$7.24 in the past 12 months.
What is AK Medical Holdings Ltd.’s market cap?
AK Medical Holdings Ltd.’s market cap is HK$6.52B.
When is AK Medical Holdings Ltd.’s upcoming earnings report date?
AK Medical Holdings Ltd.’s upcoming earnings report date is Sep 02, 2026 which is in 80 days.
How were AK Medical Holdings Ltd.’s earnings last quarter?
AK Medical Holdings Ltd. released its earnings results on Mar 25, 2026. The company reported HK$0.183 earnings per share for the quarter, beating the consensus estimate of HK$0.172 by HK$0.011.
Is AK Medical Holdings Ltd. overvalued?
According to Wall Street analysts AK Medical Holdings Ltd.’s price is currently Undervalued.
Does AK Medical Holdings Ltd. pay dividends?
AK Medical Holdings Ltd. pays a Annually dividend of HK$0.118 which represents an annual dividend yield of 1.26%. See more information on AK Medical Holdings Ltd. dividends here
What is AK Medical Holdings Ltd.’s EPS estimate?
AK Medical Holdings Ltd.’s EPS estimate is 0.19.
How many shares outstanding does AK Medical Holdings Ltd. have?
AK Medical Holdings Ltd. has 1,124,616,700 shares outstanding.
What happened to AK Medical Holdings Ltd.’s price movement after its last earnings report?
AK Medical Holdings Ltd. reported an EPS of HK$0.183 in its last earnings report, beating expectations of HK$0.172. Following the earnings report the stock price went up 2.627%.
Which hedge fund is a major shareholder of AK Medical Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1789
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AK Medical Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.55%
12-Months-Change
Fundamentals
Return on Equity
12.01%
Trailing 12-Months
Asset Growth
14.93%
Trailing 12-Months
Company Description
AK Medical Holdings Ltd.
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
1789 Stock 12 Month Forecast
Average Price Target
HK$8.08
▲(36.79% Upside)
Technical Analysis
MicroPort Scientific
―
LifeTech Scientific Corporation
―
MicroPort CardioFlow Medtech Corp.
―
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
―
Venus Medtech (Hangzhou), Inc. Class H
―
Options Prices
Currently, No data available
---